Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Cecilia Alfieri"'
Autor:
Javid Gaziev, Antonella Isgrò, Pietro Sodani, Katia Paciaroni, Gioia De Angelis, Marco Marziali, Michela Ribersani, Cecilia Alfieri, Alessandro Lanti, Tiziana Galluccio, Gaspare Adorno, Marco Andreani
Publikováno v:
Blood Advances, Vol 2, Iss 3, Pp 263-270 (2018)
Abstract: We examined outcomes of haploidentical hematopoietic cell transplantation (haplo-HCT) using T-cell receptor αβ+ (TCRαβ+)/CD19+-depleted grafts (TCR group, 14 patients) in children with hemoglobinopathies. Patients received a preparative
Externí odkaz:
https://doaj.org/article/723cc819f11041e897379fe1fb554f1d
Autor:
Antonella Isgrò, Javid Gaziev, Marco Marziali, Katia Paciaroni, Gioia De Angelis, Cecilia Alfieri, Michela Ribersani, Festus Olusola Olowoselu, Guido Lucarelli
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 9, Iss 1, Pp e2017030-e2017030 (2017)
Children with sickle cell anemia (SCA) are prone to invasive infections caused by S. pneumonia, H. influenzae, and Plasmodium falciparum. The presence of asthma increases the risk of mortality, and it has been shown an association between the presenc
Externí odkaz:
https://doaj.org/article/eece0808eaad4e048ff5c25e18f9fe0e
Autor:
Katia Paciaroni, Gioia De Angelis, Cristiano Gallucci, Cecilia Alfieri, Michela Ribersani, Andrea Roveda, Antonella Isgrò, Marco Marziali, Ivan Pietro Aloi, Alessandro Inserra, Javid Gaziev, Pietro Sodani, Guido Lucarelli
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 7, Iss 1, Pp e2015006-e2015006 (2015)
Sickle Cell Anaemia (SCA) is the most common inherited blood disorder and is associated with severe morbidity and decreased survival. Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) is the only curative approach. Nevertheless the decision
Externí odkaz:
https://doaj.org/article/0a726cdebb4d4721b7ae2ce4b32b0f63
Autor:
Marco Marziali, Antonella Isgrò, Pietro Sodani, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Cecilia Alfieri, Andrea Roveda, Gioia De Angelis, Luisa Cardarelli, Michela Ribersani, Marco Andreani, Guido Lucarelli
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 6, Iss 1, Pp e2014066-e2014066 (2014)
Allogeneic cellular gene therapy through hematopoietic stem cell transplantation is the only radical cure for congenital hemoglobinopathies like thalassemia and sickle cell anemia. Persistent mixed hematopoietic chimerism (PMC) has been described in
Externí odkaz:
https://doaj.org/article/e65dccd780f84903ad8c4c54612fc422
Autor:
Antonella Isgrò, Pietro Sodani, Marco Marziali, Javid Gaziev, Daniela Fraboni, Katia Paciaroni, Cristiano Gallucci, Gioia De Angelis, Cecilia Alfieri, Michela Ribersani, Daniele Armiento, Andrea Roveda, Marco Andreani, Manuela Testi, Guido Lucarelli
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 6, Iss 1, Pp e2014054-e2014054 (2014)
Background and Purpose: Allogeneic hematopoietic stem cell transplantation (HSCT) is the only curative treatment for sickle cell anemia (SCA). We report our experience with transplantation in children with the Black African variant of SCA and the eff
Externí odkaz:
https://doaj.org/article/d2c4a673834a4ad6935e7ce29c3b2f5a
Autor:
Afonso Armando Konzen, Airton Buzzo Alves, Alexandre Alberto de Azevedo Magalhães Jr, Alexandre de Castro Coura, Antenor Madruga, Beatriz Lopes de Oliveira, Claudia Maria de Freitas Chagas, Cristiane Corrêa de Souza Hillal, Danielle de Guimarães Germano Arlé, Dermeval Farias Gomes Filho, Douglas Fischer, Eduardo Marcelo Mistrorigo de Freitas, Elton Venturi, Flávia Mussi Bueno do Couto, Francisco Martinez Berdeal, Graziella Maria Deprá Bittencourt Gadelha, Gregório Assagra de Almeida, Hermes Zaneti Jr, Isabela de Deus Cordeiro, Jairo Cruz Moreira, Jarbas Soares Júnior, Katiane Boschetti da Silveira, Luciana Gomes Ferreira de Andrade, Luciano Luz Badini Martins, Marcos Pereira Anjo Coutinho, Maria Cecília Alfieri Nacle, Maria Clara Mendonça Perim, Mariana Andrade Covre, Mônica Lodder de Oliveira dos Santos Pereira, Patricia de Carvalho Leitão, Paulo Valério Dal Pai Moraes, Rachel Ivanir Marques dos Santos, Rafael Calhau Bastos, Rafaela Duso, Renata Gonçalves de Oliveira, Ricardo de Barros Leonel, Roberto Luís de Oliveira
'Esta substanciosa obra a respeito da atuação do Ministério Público na resolução consensual e no tratamento adequado dos conflitos envolvendo direitos fundamentais, foi concebida sob o importante enfoque, que nos é muito caro, de acesso efetiv
Autor:
Michela Ribersani, Katia Paciaroni, Pietro Sodani, Javid Gaziev, Gioia De Angelis, Cecilia Alfieri, Marco Marziali, Antonella Isgrò, Mario Dauri
Publikováno v:
Bone Marrow Transplantation. 54:1121-1123
To candidate children as bone marrow donors raises two main concerns: donor safety and adequate marrow cell dose. Data in the field are limited and guidelines for child donor care management are lacking. In this context, we herein report the experien
Autor:
Alessandro Lanti, Gaspare Adorno, Marco Marziali, Michela Ribersani, Marco Andreani, Katia Paciaroni, Javid Gaziev, Antonella Isgrò, Pietro Sodani, Cecilia Alfieri, Tiziana Galluccio, Gioia De Angelis
We examined outcomes of haploidentical hematopoietic cell transplantation (haplo-HCT) using T-cell receptor αβ+ (TCRαβ+)/CD19+-depleted grafts (TCR group, 14 patients) in children with hemoglobinopathies. Patients received a preparative regimen c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acf14a434d2e1ec92015af48410a9e1c
https://europepmc.org/articles/PMC5812329/
https://europepmc.org/articles/PMC5812329/
Autor:
Marco Andreani, Alessia Francesca Mozzi, Aurélie Pétain, Pietro Sodani, Cecilia Alfieri, Manuela Testi, Michela Ribersani, Cristiano Ialongo, Cristiano Gallucci, Laurent Nguyen, Antonella Isgrò, Katia Paciaroni, Guido Lucarelli, Javid Gaziev, Vincenzo Dinallo, Gioia De Angelis, Marco Marziali
Publikováno v:
Pediatric Blood & Cancer. 62:680-686
Background Busulfan (Bu) is an integral part of conditioning regimens for patients with sickle cell anemia (SCA) undergoing transplantation. Patients with SCA might predispose to transplant-related neurological and pulmonary toxicities due to pre-exi
Autor:
Andrea Romigi, Francesca Di Giuliano, Francesca Izzi, Marco Marziali, Michela Ribersani, Marco Andreani, Giorgia Rossi, Fabio Placidi, Javid Gaziev, Gioia De Angelis, Cecilia Alfieri, Katia Paciaroni, Simone Marziali, Antonella Isgrò, Maria Giuseppina Palmieri, Nicola Biagio Mercuri, Roberto Floris
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(9)
Posterior reversible encephalopathy syndrome (PRES) is a serious adverse event associated with calcineurin inhibitors used for graft-versus-host disease (GVHD) prophylaxis. We compared the incidence of PRES in children with thalassemia (n = 222, 1.4